123 related articles for article (PubMed ID: 37906983)
1. Brain Injury Outcomes after Adjuvant Erythropoietin Neuroprotection for Moderate or Severe Neonatal Hypoxic-Ischemic Encephalopathy: A Report from the HEAL Trial.
Wisnowski JL; Monsell SE; Bluml S; Goodman AM; Li Y; Comstock B; Heagerty P; Juul SE; Wu YW; McKinstry RC; Mathur A;
Dev Neurosci; 2023 Oct; ():. PubMed ID: 37906983
[TBL] [Abstract][Full Text] [Related]
2. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol.
Juul SE; Comstock BA; Heagerty PJ; Mayock DE; Goodman AM; Hauge S; Gonzalez F; Wu YW
Neonatology; 2018; 113(4):331-338. PubMed ID: 29514165
[TBL] [Abstract][Full Text] [Related]
3. Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo.
Glass HC; Wusthoff CJ; Comstock BA; Numis AL; Gonzalez FF; Maitre N; Massey SL; Mayock DE; Mietzsch U; Natarajan N; Sokol GM; Bonifacio SL; Van Meurs KP; Thomas C; Ahmad KA; Heagerty PJ; Juul SE; Wu YW
Pediatr Res; 2023 Jul; 94(1):252-259. PubMed ID: 36470964
[TBL] [Abstract][Full Text] [Related]
4. Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial.
Juul SE; Voldal E; Comstock BA; Massaro AN; Bammler TK; Mayock DE; Heagerty PJ; Wu YW; Numis AL;
JAMA Netw Open; 2023 Jul; 6(7):e2322131. PubMed ID: 37418263
[TBL] [Abstract][Full Text] [Related]
5. Impact of Erythropoietin in the management of Hypoxic Ischaemic Encephalopathy in resource-constrained settings: protocol for a randomized control trial.
Ezenwa B; Ezeaka C; Fajolu I; Ogbenna A; Olowoyeye O; Nwaiwu O; Opoola Z; Olorunfemi G
BMC Neurol; 2020 May; 20(1):171. PubMed ID: 32366288
[TBL] [Abstract][Full Text] [Related]
6. High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.
Wu YW; Mathur AM; Chang T; McKinstry RC; Mulkey SB; Mayock DE; Van Meurs KP; Rogers EE; Gonzalez FF; Comstock BA; Juul SE; Msall ME; Bonifacio SL; Glass HC; Massaro AN; Dong L; Tan KW; Heagerty PJ; Ballard RA
Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244862
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research.
Oorschot DE; Sizemore RJ; Amer AR
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098276
[TBL] [Abstract][Full Text] [Related]
8. Active cooling temperature required to achieve therapeutic hypothermia correlates with short-term outcome in neonatal hypoxic-ischaemic encephalopathy.
Mietzsch U; Radhakrishnan R; Boyle FA; Juul S; Wood TR
J Physiol; 2020 Jan; 598(2):415-424. PubMed ID: 31777079
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis.
Razak A; Hussain A
J Perinat Med; 2019 May; 47(4):478-489. PubMed ID: 30789826
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial.
Malla RR; Asimi R; Teli MA; Shaheen F; Bhat MA
J Perinatol; 2017 May; 37(5):596-601. PubMed ID: 28277490
[TBL] [Abstract][Full Text] [Related]
11. Mild hypoxic-ischemic encephalopathy (HIE): timing and pattern of MRI brain injury.
Li Y; Wisnowski JL; Chalak L; Mathur AM; McKinstry RC; Licona G; Mayock DE; Chang T; Van Meurs KP; Wu TW; Ahmad KA; Cornet MC; Rao R; Scheffler A; Wu YW
Pediatr Res; 2022 Dec; 92(6):1731-1736. PubMed ID: 35354930
[TBL] [Abstract][Full Text] [Related]
12. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.
Traudt CM; McPherson RJ; Bauer LA; Richards TL; Burbacher TM; McAdams RM; Juul SE
Dev Neurosci; 2013; 35(6):491-503. PubMed ID: 24192275
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Neuropathological Changes Associated with Cerebral Palsy in a Nonhuman Primate Model of Hypoxic-Ischemic Encephalopathy.
McAdams RM; Fleiss B; Traudt C; Schwendimann L; Snyder JM; Haynes RL; Natarajan N; Gressens P; Juul SE
Dev Neurosci; 2017; 39(1-4):124-140. PubMed ID: 28486224
[TBL] [Abstract][Full Text] [Related]
14. Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III).
Maiwald CA; Annink KV; Rüdiger M; Benders MJNL; van Bel F; Allegaert K; Naulaers G; Bassler D; Klebermaß-Schrehof K; Vento M; Guimarães H; Stiris T; Cattarossi L; Metsäranta M; Vanhatalo S; Mazela J; Metsvaht T; Jacobs Y; Franz AR;
BMC Pediatr; 2019 Jun; 19(1):210. PubMed ID: 31248390
[TBL] [Abstract][Full Text] [Related]
15. Whole-Body Hypothermia, Cerebral Magnetic Resonance Biomarkers, and Outcomes in Neonates With Moderate or Severe Hypoxic-Ischemic Encephalopathy Born at Tertiary Care Centers vs Other Facilities: A Nested Study Within a Randomized Clinical Trial.
Thayyil S; Montaldo P; Krishnan V; Ivain P; Pant S; Lally PJ; Bandiya P; Benkappa N; Kamalaratnam CN; Chandramohan R; Manerkar S; Mondkar J; Jahan I; Moni SC; Shahidullah M; Rodrigo R; Sumanasena S; Sujatha R; Burgod C; Garegrat R; Mazlan M; Chettri I; Babu Peter S; Joshi AR; Swamy R; Chong K; Pressler RR; Bassett P; Shankaran S
JAMA Netw Open; 2023 May; 6(5):e2312152. PubMed ID: 37155168
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.
Rogers EE; Bonifacio SL; Glass HC; Juul SE; Chang T; Mayock DE; Durand DJ; Song D; Barkovich AJ; Ballard RA; Wu YW
Pediatr Neurol; 2014 Nov; 51(5):657-62. PubMed ID: 25439577
[TBL] [Abstract][Full Text] [Related]
17. Diffusion Tensor Imaging Detects Occult Cerebellar Injury in Severe Neonatal Hypoxic-Ischemic Encephalopathy.
Lemmon ME; Wagner MW; Bosemani T; Carson KA; Northington FJ; Huisman TAGM; Poretti A
Dev Neurosci; 2017; 39(1-4):207-214. PubMed ID: 28095379
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy?
Wu YW; Gonzalez FF
Dev Med Child Neurol; 2015 Apr; 57 Suppl 3():34-9. PubMed ID: 25800490
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use.
Perrone S; Lembo C; Gironi F; Petrolini C; Catalucci T; Corbo G; Buonocore G; Gitto E; Esposito SMR
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453337
[TBL] [Abstract][Full Text] [Related]
20. Utilization of Therapeutic Hypothermia and Neurological Injury in Neonates with Mild Hypoxic-Ischemic Encephalopathy: A Report from Children's Hospital Neonatal Consortium.
Rao R; Mietzsch U; DiGeronimo R; Hamrick SE; Dizon MLV; Lee KS; Natarajan G; Yanowitz TD; Peeples ES; Flibotte J; Wu TW; Zaniletti I; Mathur AM; Massaro A
Am J Perinatol; 2022 Feb; 39(3):319-328. PubMed ID: 32892328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
